Home About Us Services Markets Resarch Online Trading Back Office Contact Us Download
Glaxosmithkline Pharmaceuticals Ltd Pharmaceuticals - Multinational
 BSE Code
 500660
ISIN Demat
INE159A01016
Book Value
91.3566062
Mar.Cap(Rs.Cr)
35,635.41
P/E
56.06
Face Value
10
Go
Your are on :   Markets   |  Company Profile   |  Balance Sheet
ParticularsMar 2023
(Rs.Cr)
Mar 2022
(Rs.Cr)
Mar 2021
(Rs.Cr)
Mar 2020
(Rs.Cr)
Mar 2019
(Rs.Cr)
Mar 2018
(Rs.Cr)
SOURCES OF FUNDS :      
Share Capital 169.41169.41169.41169.41169.4184.70
Reserves Total 1583.592508.211327.711670.631973.011995.25
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds1753.002677.621497.121840.042142.422079.95
Secured Loans 0.000.000.000.000.000.00
Unsecured Loans 15.5420.0834.630.180.580.99
Total Debt15.5420.0834.630.180.580.99
Other Liabilities254.22263.00260.29289.39315.72288.44
Total Liabilities2022.762960.701792.042129.612458.722369.38
APPLICATION OF FUNDS :      
Gross Block 635.93593.89602.891454.59561.30408.14
Less : Accumulated Depreciation 305.99263.26216.00696.53129.6983.57
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 329.94330.63386.89758.06431.61324.57
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress20.3130.5013.21120.121002.64922.90
Producing Properties0.000.000.000.000.000.00
Investments 542.78390.0924.4924.4924.5547.67
Current Assets, Loans & Advances      
Inventories 437.70512.71523.34483.03486.49500.18
Sundry Debtors 192.38205.24215.6099.80120.49146.96
Cash and Bank Balance1150.732479.111157.681066.411155.331279.69
Loans and Advances 167.62108.05274.71107.54228.87236.21
Total Current Assets1948.433305.122171.331756.781991.182163.05
Less : Current Liabilities and Provisions      
Current Liabilities 590.941046.53866.70559.871205.151344.46
Provisions 713.99615.36438.35442.04245.32251.18
Total Current Liabilities & Provisions1304.941661.901305.051001.921450.471595.64
Net Current Assets643.491643.22866.28754.86540.71567.41
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets151.38131.67117.24126.0984.60119.26
Deferred Tax Liability18.2018.8915.5717.2424.1216.20
Net Deferred Tax133.18112.78101.67108.8560.48103.06
Other Assets353.06453.48399.49363.22398.72403.78
Total Assets2022.762960.701792.032129.602458.712369.39
Contingent Liabilities350.59351.10485.78471.42512.80637.85
Product Disclaimer Mandatory Information Privacy Policy Careers Risk disclosures Feedback Scores Member Bank Details
"Investor Grievance" Mail your Grievance to info@lalkar.in Important Links:   SEBI  |  NSE  |  BSE  |  MCX-SX  |  MCX   |   NCDEX  |  NSDL  |  CDSL  |  FMC   |   CDSL E-Voting  |  SMART ODR
SEBI REGISTRATION NOS - BSE CASH: INZ000269434  |  BSE FNO: INZ000269434  |  NSE CASH: INZ000269434  |  NSE FNO: INZ000269434  |  NSE CD: INZ000269434  |  MSEI CASH: INZ000269434   |   MSEI FNO: INZ000269434   |   MSEI CD: INZ000269434
AMFI NO : ARN- 19226  |  LALKAR COMMODITIES PVT. LTD.: MCX: 10685 FMC: MCX/TCM/CORP/0655 | NSEL: 11300 | NCDEX: 1130 FMC No : NCDEX/TCM/CORP/1106
2010 © Lalkar Group. All rights reserved Designed, developed & powered by CMOTS Infotech(ISO 9001:2015 certified)